Biochemical and toxicological evaluation of agent-cofactor reactivity as a mechanism of action for osteolathyrism.

作者: Douglas A. Dawson , Andrea C. Rinaldi , Gerald Pöch

DOI: 10.1016/S0300-483X(02)00233-0

关键词: Reactivity (chemistry)CofactorLysyl oxidaseOsteolathyrismStereochemistryAminoacetonitrileBeta aminopropionitrileSemicarbazideMechanism of actionChemistry

摘要: In vitro reactivity for each of four osteolathyrogens with a model compound the lysyl oxidase (LO) cofactor was evaluated and coupled mixture toxicity testing to evaluate agent-cofactor as potential mechanism action osteolathyrism. Reactivity (mLTQ: 4-butylamino-5-methyl-o-quinone), two ureides, semicarbazide (SC) thiosemicarbazide (TSC), aminonitriles, aminoacetonitrile (AAN) β-aminopropionitrile (βAPN), assessed using UV–vis spectrophotometry; both in absence presence Cu(II)–bipyridine (bipy) complex. Two sets experiments were conducted frog embryo assay that incidence osteolathyrism notochord tadpoles after 96-h exposure. The resulting concentration–response curves set (χ2 goodness-of-fit test) against theoretical combined effects models: dose–addition independence, determine effect osteolathyrogen combination. agents SC, TSC AAN showed rapid, irreversible mLTQ, Cu(II)–bipy complex, indicated by bleaching mLTQ peak (504 nm) formation an adduct at 350 nm. βAPN no apparent prolonged incubation whether complex present or not. After (24–144 h) new formed nm, suggesting reacts weakly cofactor, but manner different from other examined. tests dose-additive SC:TSC, AAN:SC AAN:SC:TSC mixtures (0.1

参考文章(58)
Marcos Rojkind, Ruy Pérez-Tamayo, Molecular pathology of connective tissues M. Dekker. ,(1973)
Saul Patai, The Chemistry of the carbonyl group Interscience Publishers. ,(1966)
Pöch G, Holzmann S, Dittrich P, Dose-response curves of vasorelaxants: computerized calculation of combination effects using the example of nicorandil Journal of clinical and basic cardiology. ,vol. 2, pp. 96- 98 ,(1999)
C I Levene, M J Carrington, The inhibition of protein-lysine 6-oxidase by various lathyrogens: evidence for two different mechanisms Biochemical Journal. ,vol. 232, pp. 293- 296 ,(1985) , 10.1042/BJ2320293
P Leff, An analysis of amplifying and potentiating interactions between agonists. Journal of Pharmacology and Experimental Therapeutics. ,vol. 243, pp. 1035- 1042 ,(1987)
Angela M. Gaudet-Hull, James R. Rayburn, John A. Bantle, Dennis T. Burton, Steven D. Turley, Douglas A. Dawson, James N. Dumont, Robert A. Finch, Margaret A. Maurice, Douglas J. Fort, Greg Linder, David Buchwalter, Fetax interlaboratory validation study: Phase II testing Environmental Toxicology and Chemistry. ,vol. 13, pp. 1629- 1637 ,(1994) , 10.1002/ETC.5620131012
S. X. Wang, M. Mure, K. F. Medzihradszky, A. L. Burlingame, D. E. Brown, D. M. Dooley, A. J. Smith, H. M. Kagan, J. P. Klinman, A Crosslinked Cofactor in Lysyl Oxidase: Redox Function for Amino Acid Side Chains Science. ,vol. 273, pp. 1078- 1084 ,(1996) , 10.1126/SCIENCE.273.5278.1078
Guanmei Liu, Kaliappanadar Nellaiappan, Herbert M. Kagan, Irreversible Inhibition of Lysyl Oxidase by Homocysteine Thiolactone and Its Selenium and Oxygen Analogues IMPLICATIONS FOR HOMOCYSTINURIA Journal of Biological Chemistry. ,vol. 272, pp. 32370- 32377 ,(1997) , 10.1074/JBC.272.51.32370